èšåºæ®µéã®ãã€ãªå»è¬åäŒç€Ÿã§ãã Madrigal Pharmaceuticals, Inc. ã¯ãå¿è¡ç®¡çŸæ£ã代è¬çŸæ£ãèèçŸæ£ã®æ²»çè¬åè£ã®éçºãšåååã«æ³šåããŠããŸããå瀟ã®äž»å補ååè£ã¯ãèèãæšçãšããéžæçç²ç¶è
ºãã«ã¢ã³å容äœÎ²äœåè¬ã§ãã MGL-3196 ã§ãéã¢ã«ã³ãŒã«æ§èèªèçã®æ²»çè¬ãšããŠç¬¬ III çžèšåºè©Šéšäžã§ããå瀟ã¯ãããã³ã»ã©ã»ãã·ã¥ãšç ç©¶ãéçºãåååå¥çŽãçµãã§ããŸããMadrigal Pharmaceuticals, Inc. ã®æ¬ç€Ÿã¯ããã³ã·ã«ããã¢å·ãŠã§ã¹ãã»ã³ã³ã·ã§ããã±ã³ã«ãããŸãã